标题
Momelotinib therapy for myelofibrosis: a 7-year follow-up
作者
关键词
-
出版物
Blood Cancer Journal
Volume 8, Issue 3, Pages -
出版商
Springer Nature
发表日期
2018-03-07
DOI
10.1038/s41408-018-0067-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis
- (2018) Paola Guglielmelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis
- (2017) A Pardanani et al. LEUKEMIA
- Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management
- (2016) Ayalew Tefferi AMERICAN JOURNAL OF HEMATOLOGY
- Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes
- (2016) Eline M.P. Cremers et al. HAEMATOLOGICA
- Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes
- (2016) Eline M.P. Cremers et al. HAEMATOLOGICA
- Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia
- (2014) Lisa Pieri et al. AMERICAN JOURNAL OF HEMATOLOGY
- Momelotinib treatment-emergent neuropathy: prevalence, risk factors and outcome in 100 patients with myelofibrosis
- (2014) Ramy A. Abdelrahman et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
- (2014) A Pardanani et al. LEUKEMIA
- Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report
- (2013) A. Tefferi et al. BLOOD
- Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
- (2013) A Pardanani et al. LEUKEMIA
- CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms
- (2010) J. W. Tyner et al. BLOOD
- DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
- (2010) Naseema Gangat et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started